Hydrochloric Acid

Hydrochloric Acid

SCHEMBL173970

CCCCCCCCN(C)C.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.42
S1PR2 known ✓ O95136 1/20 0.41
S1PR1 known ✓ P21453 1/20 0.41
S1PR3 known ✓ Q99500 1/20 0.41
S1PR5 known ✓ Q9H228 1/20 0.41
DNM1 Q05193 10/20 1.00
TSHR P16473 2/20 0.69
ALDH1A1 P00352 1/20 0.69
THRB P10828 1/20 0.50
GBA1 P04062 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL186835 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL20142868 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL4581667 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL25273059 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL19327730 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL25273058 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL11211039 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL564629 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL237081 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1
Hydrochloric Acid SCHEMBL8369176 1.00 DNM1 (1.00) DNM1TSHRALDH1A1THRBGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874444-A Heavy metal adsorption slow release fertilizer and preparation method and application thereof 国家烟草质量监督检验中心 2025-04-25 CN claimed
CN-119650599-A Preparation method of hard carbon negative electrode suitable for sodium ion battery with high first efficiency and ultrahigh specific capacity 扬州大学 2025-03-18 CN claimed
CN-119331295-A Extinction liquid for lens shading sheet, extinction lens shading sheet, preparation method and application of extinction liquid 拓烯科技(衢州)有限公司 2025-01-21 CN claimed
CN-119081428-A Modified emulsified asphalt for preventing and curing asphalt pavement as well as preparation method and application thereof 招商智翔道路科技(重庆)有限公司 2024-12-06 CN claimed
CN-119061112-A Alpha-L-fucosidase detection reagent or kit and preparation method thereof 中生北控生物科技股份有限公司 2024-12-03 CN claimed
CN-115420698-B Method for detecting content of hyaluronic acid in textile 江苏金太阳纺织科技股份有限公司 2024-10-29 CN claimed
CN-118831456-A Composite self-cleaning film based on waste lithium battery anode material and preparation method and application thereof 上海交通大学 2024-10-25 CN claimed
CN-114921865-B Regenerated cellulose fiber containing nanometer particles of extracts of avocado and shea and preparation method thereof 邦特云纤(青岛)新材料科技有限公司 2024-04-05 CN claimed
CN-117778114-A Special antistatic dry cleaning agent for down jackets and preparation method thereof 宝斯卡(商丘)化工有限公司 2024-03-29 CN claimed
CN-117769588-A Methods and reagents for enhancing chemiluminescent signals 欧蒙医学实验诊断股份公司 2024-03-26 CN claimed
US-6946490-B2 Antimicrobial treatment for herpes simplex virus and other infectious diseases MCGINLEY PARTNERS, LLC (US) 2005-09-20 US claimed
EP-0684952-B1 METHOD FOR THE IMMOBILIZATION OF NUCLEIC ACID MOLECULES BECKMAN COULTER INC (US) 2004-10-13 EP claimed
US-20040020105-A1 Emulsified water fuel blend containing an aqueous organic ammonium salt THE LUBRIZOL CORPORATION A CORPORATION OF THE STATE OF OHIO 2004-02-05 US claimed
EP-0918458-A4 ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 2004-01-02 EP claimed
US-20030104082-A1 Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases MCGINLEY PARTNERS, LLC (US) 2003-06-05 US claimed
US-20030099726-A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases MCGINLEY PARTNERS, LLC (US) 2003-05-29 US claimed
US-6355684-B1 AQUEOUS BENZALKONIUM CHLORIDE, ECHINACEA AND ANTIMICROBIAL ISOLATES; VIRICIDES FOR PAPILLOMA, VARICELLA-ZOSTER, AND CYTOMEGALO VIRUSE; HIGH SPEED ANALGESIC; HEALING OF LESIONS; TOPICAL ADMINISTERING Squires, Meryl J. 2002-03-12 US claimed
EP-0918458-A1 ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES Squires, Meryl (US) 1999-06-02 EP claimed
WO-1998011778-A1 ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 1998-03-26 WO claimed
US-5610287-A ON A HYDROPHILLIC POLYSTYRENE SOILD SUPPORT IN THE PRESENCE OF A SALT OR CATIONIC DETERGENT MOLECULAR TOOL, INC. (US) 1997-03-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030099726-A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases KCNJ11, KCNJ1, TRPA1 CA2 3258/4885S1PR2 175/4885S1PR1 38/4885
US-20030104082-A1 Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases CD14, CD59, SLC19A1 CA2 3783/4885S1PR2 522/4885S1PR1 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.